Farmakokinetik ve Farmakodinamik Mekanizmaların İlaç Etkileşimine Etkisinin İncelenmesi

Alvim MM, Silva LA, Leite IC, Silvério MS. Adverse events caused by potential drug-drug interactions in an intensive care unit of a teaching hospital. Rev Bras Ter Intensiva. 2015;27(4):353-9.

Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust. 1998;168(8):405-8.

Rivkin A. Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm. 2007;64(17):1840-3.

Kristensen MB. Drug interactions and clinical pharmacokinetics. Clin Pharmacokinet. 1976;1(5):351-72.

Barr WH, Adir J, Garrettson L. Decrease of tetracycline absorption in man by sodium bicarbonate. Clin Pharmacol Ther. 1971;12(5):779-84.

Bint AJ, Burtt I. Adverse antibiotic drug interactions. Drugs. 1980;20(1):57-68.

Ferreira Silva R, Rita Carvalho Garbi Novaes M. Interactions between drugs and drug-nutrient in enteral nutrition: a review based on evidences. Nutr Hosp. 2014;30(3):514-8.

Nation RL, Evans AM, Milne RW. Pharmacokinetic drug interactions with phenytoin (Part I). Clin Pharmacokinet. 1990;18(1):37-60.

Trynda-Lemiesz L, Wiglusz K. Interactions of human serum albumin with meloxicam: characterization of binding site. J Pharm Biomed Anal. 2010;52(2):300-4.

Edwards DJ, Lalka D, Cerra F, Slaughter RL. Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther. 1982;31(1):62-7.

Michalets EL. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy. 1998;18(1):84-112.

Antoniou T, Gomes T, Mamdani MM, Juurlink DN. Ciprofloxacin-induced theophylline toxicity: a population-based study. Eur J Clin Pharmacol. 2011;67(5):521-6.

Batty KT, Davis TM, Ilett KF, Dusci LJ, Langton SR. The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 1995;39(3):305-11.

Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med. 2004;351(11):1089-96.

Saari TI, Laine K, Neuvonen M, Neuvonen PJ, Olkkola KT. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. Eur J Clin Pharmacol. 2008;64(1):25-30.

Hughes J, Crowe A. Inhibition of P-glycoprotein-mediated efflux of digoxin and its metabolites by macrolide antibiotics. J Pharmacol Sci. 2010;113(4):315-24.

Ivanyuk A, Livio F, Biollaz J, Buclin T. Renal Drug Transporters and Drug Interactions. Clin Pharmacokinet. 2017;56(8):825-92.

Papadopoulos J, Smithburger PL. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations. Crit Care Med. 2010;38(6 Suppl):S126-35.